
Centene Corporation CNC
$ 39.89
0.73%
Annual report 2024
added 02-18-2025
Country |
|
IPO year |
- |
Industry |
Health care |
Stock Exchange |
NYSESPB |
Shares |
522 M |
Market Cap[1] |
$ 20.8 B |
EBITDA (LTM) |
$ 3.57 B |
P/E (LTM) |
14.56 |
P/S (LTM) |
0.16 |
EPS (LTM) |
2.74 |
Other stocks of industry "Health care"
| Issuer | Price | % 24h | Market Cap | Exchange | Country | |
|---|---|---|---|---|---|---|
|
Anthem
ANTM
|
- | -2.32 % | $ 107 B | NYSE,SPB | ||
|
Cigna Corporation
CI
|
$ 274.86 | 0.41 % | $ 75.3 B | NYSE,SPB | ||
|
Humana
HUM
|
$ 259.25 | 0.83 % | $ 31.3 B | NYSE,SPB | ||
|
Triple-S Management Corporation
GTS
|
- | 0.28 % | $ 847 M | NYSE | ||
|
Magellan Health, Inc.
MGLN
|
- | -0.19 % | $ 2.49 B | Nasdaq Global Select Market,SPB | ||
|
Molina Healthcare
MOH
|
$ 163.47 | -0.34 % | $ 9.38 B | NYSE,SPB | ||
|
CVS Health Corporation
CVS
|
$ 79.12 | 1.38 % | $ 99.6 B | NYSE,SPB | ||
|
UnitedHealth Group Inc.
UNH
|
$ 327.58 | 0.86 % | $ 302 B | NYSE,SPB | ||
|
NovoCure Limited
NVCR
|
$ 13.44 | 1.28 % | $ 1.45 B | Nasdaq Global Select Market,SPB |
References
- Pavone, P. (2019). Market capitalization and financial variables: Evidence from Italian listed companies. International Journal of Academic Research Business and Social Sciences, 9(3), 1356-1371.